LATEST
Cencora agreed to acquire American Oncology NetworknewAPEX / KorainewSmith & Wesson Brands agreed to acquire Long Range IntermediatenewMaximus Federal Services agreed to acquire Agile DefenseMount Logan Management agreed to acquire Alternative Fund AdvisorsDime Commercial Bancshares / ES BancsharesSalesforce agreed to acquire BrazeJV Investors / Oro Mobility HoldingsMorgan Stanley Capital Partners acquired The Rapid GroupCBRE Group agreed to acquire Onnec GroupBevPoint Capital agreed to acquire ESGMarwynn Holdings acquired Zhituo Software
Open App
ClosedPublished 15 Mar 2023

Organovo, Inc. /
Metacrine, Inc.

Organovo, Inc. buys Metacrine, Inc. FXR program

Price
$4m
Stage
Closed
Buy side: Organovo, Inc.
Buy sideOrganovo, Inc.
Target: Metacrine, Inc.
TargetMetacrine, Inc.
Source · 15 Mar 2023
See the source
Buy side: Organovo, Inc.
Buy sideOrganovo, Inc.
Target: Metacrine, Inc.
TargetMetacrine, Inc.
01 / BuyerOrganovo, Inc.
02 / TargetMetacrine, Inc.
01

What happened

Organovo, Inc., a wholly-owned subsidiary of Organovo Holdings, Inc., closed an asset purchase agreement with Metacrine, Inc. for its FXR program.

Cash payments total $4 million, with $2 million paid at closing and the remaining $2 million due shortly after the transfer is complete.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Organovo, Inc. buys Metacrine, Inc. FXR program

This document is the source for the companies, stage, figure and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.